Our Programs

Our goal is to advance targeted treatments for cancer patients who need new options. We are focused on developing novel therapies that correct the dysregulated gene expression of diseased cells to inhibit cancer progression. To accomplish this, we target proteins involved in regulating gene expression: epigenetic proteins and transcription factors.